正文

How to choose between Peg-Interferon and Nucleos(t)ide analogues in Chronic Hepatitis B

来源：国际肝病作者：Harry L.A. Janssen发布时间：2009-5-13阅读：1122
内容简介：Conclusions :Major improvement in therapeutic options over the last decade.Try to aim for sustained off-treatment response.Choice of therapy depends on individual patient characteristics: PEG-IFN in selected proportion of patients
编辑：yangxinxiang
内容标签：Chronic Hepatitis B


相关新闻：

 

会议简介

    [APASL2009]...We, the APASL, envisage, in the next ten years, the availability of new innovative approach, in therapeutic and diagnostics areas, to be introduced to the clinical practice of hepatology. The driving dynamo behind these developments will rely heavily on the effective and candid collaboration and communication查看详细>>
 

资源统计

 
©2008 www.ihepa.com 京ICP备07005963号
我要啦免费统计